BBSRC Portfolio Analyser
Award details
Feasibility and Benchmarking of RiboTite gene expression control technology
Reference
BB/J019089/1
Principal Investigator / Supervisor
Professor Jason Micklefield
Co-Investigators /
Co-Supervisors
Dr Neil Dixon
Institution
The University of Manchester
Department
Chemistry
Funding type
Research
Value (£)
146,160
Status
Completed
Type
Research Grant
Start date
18/06/2012
End date
17/09/2013
Duration
15 months
Abstract
unavailable
Summary
We have developed a novel gene expression technology that has applications in the R&D kits market and in the manufacture of biopharmaceuticals. We plan through this current study to benchmark our expression technology against those systems currently available in the marketplace. This study will showcase the key areas of technical superiority of our technology, inform its subsequent positioning in the market place, inform our business planning and act as an enabling primer for private equity investment. The outputs from this grant will lead to partnering collaborations with industry, provide impact for BBSRC funded research, and potentially lead to wealth generation and job creation for the UK.
Committee
Not funded via Committee
Research Topics
Industrial Biotechnology, Pharmaceuticals, Technology and Methods Development
Research Priority
X – Research Priority information not available
Research Initiative
Follow-On Fund (FOF) [2004-2015]
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search